ProKidney Statistics

Total Valuation

ProKidney has a market cap or net worth of $602.24 million. The enterprise value is $279.19 million.

Market Cap	602.24M
Enterprise Value	279.19M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, before market open.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

ProKidney has 285.42 million shares outstanding. The number of shares has decreased by -0.96% in one year.

Shares Outstanding	285.42M
Shares Change (YoY)	-0.96%
Shares Change (QoQ)	-1.95%
Owned by Insiders (%)	30.48%
Owned by Institutions (%)	28.77%
Float	39.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.62

Current Ratio	17.62
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,774.27

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-8.10%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$216,534
Employee Count	163
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ProKidney has paid $4.77 million in taxes.

Income Tax	4.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.23% in the last 52 weeks. The beta is 1.31, so ProKidney's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-81.23%
50-Day Moving Average	2.92
200-Day Moving Average	2.11
Relative Strength Index (RSI)	38.68
Average Volume (20 Days)	657,515

Short Selling Information

The latest short interest is 10.29 million, so 3.60% of the outstanding shares have been sold short.

Short Interest	10.29M
Short Previous Month	10.18M
Short % of Shares Out	3.60%
Short % of Float	25.86%
Short Ratio (days to cover)	8.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-150.72M
Pretax Income	-30.53M
Net Income	-35.30M
EBITDA	-26.39M
EBIT	-30.52M
Earnings Per Share (EPS)	-$0.57

Full Income Statement

Balance Sheet

The company has $329.00 million in cash and $5.95 million in debt, giving a net cash position of $323.05 million or $1.13 per share.

Cash & Cash Equivalents	329.00M
Total Debt	5.95M
Net Cash	323.05M
Net Cash Per Share	$1.13
Equity (Book Value)	-1.10B
Book Value Per Share	-3.84
Working Capital	320.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$98.72 million and capital expenditures -$34.17 million, giving a free cash flow of -$132.89 million.

Operating Cash Flow	-98.72M
Capital Expenditures	-34.17M
Free Cash Flow	-132.89M
FCF Per Share	-$2.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProKidney does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.96%
Shareholder Yield	0.96%
Earnings Yield	-5.86%
FCF Yield	-22.07%

Dividend Details

Analyst Forecast

The average price target for ProKidney is $7.25, which is 243.60% higher than the current price. The consensus rating is "Buy".

Price Target	$7.25
Price Target Difference	243.60%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	Jul 12, 2022
Split Type	n/a
Split Ratio	1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1